Literature DB >> 25392020

Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy.

Seiya Shimoda1, Mina Okubo, Kotaro Koga, Taiji Sekigami, Junji Kawashima, Daisuke Kukidome, Motoyuki Igata, Norio Ishii, Akiko Shimakawa, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida, Eiichi Araki.   

Abstract

To assess the total daily inulin dose (TDD) and contribution of basal insulin to TDD and to identify the predictive factors for insulin requirement profiles in subjects with type 2 diabetes, we retrospectively examined insulin requirement profiles of 275 hospitalized subjects treated with basal-bolus insulin therapy (BBT) (mean age, 60.1 ± 12.9 years; HbA1c, 10.2 ± 4.5%). Target plasma glucose level was set between 80 and 129 mg/dL before breakfast and between 80 and 179 mg/dL at 2-hour after each meal without causing hypoglycemia. We also analyzed the relationship between the insulin requirement profiles (TDD and basal/total daily insulin ratio [B/TD ratio]) and insulin-associated clinical parameters. The mean TDD was 0.463 ± 0.190 unit/kg/day (range, 0.16-1.13 unit/kg/day). The mean B/TD ratio was 0.300 ± 0.099 (range, 0.091-0.667). A positive correlation of TDD with B/TD ratio was revealed by linear regression analysis (r=0.129, p=0.03). Stepwise multiple regression analysis identified post-breakfast glucose levels before titrating insulin as an independent determinant of the insulin requirement profile [Std β (standard regression coefficient) = 0.228, p<0.01 for TDD, Std β = -0.189, p<0.01 for B/TD ratio]. The TDD was <0.6 unit/kg/day and the B/TD ratio was <0.4 in the majority (70.2%) of subjects in the present study. These findings may have relevance in improving glycemic control and decreasing the risk of hypoglycemia and weight gain in subjects with type 2 diabetes treated with BBT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25392020     DOI: 10.1507/endocrj.EJ14-0487

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

Review 1.  Novel trends and concepts in the nutritional management of glycemia in type 2 diabetes mellitus-beyond dietary patterns: a narrative review.

Authors:  Zoe Pafili; Charilaos Dimosthenopoulos
Journal:  Hormones (Athens)       Date:  2021-08-29       Impact factor: 2.885

2.  Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes.

Authors:  Kazuma Ogiso; Nobuyuki Koriyama; Takahiko Obo; Akinori Tokito; Yoshihiko Nishio
Journal:  Diabetol Int       Date:  2020-08-03

3.  Excess weight gain during insulin pump therapy is associated with higher basal insulin doses.

Authors:  Claudia Boucher-Berry; Elaine A Parton; Ramin Alemzadeh
Journal:  J Diabetes Metab Disord       Date:  2016-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.